Platinum coordination complexes in cancer chemotherapy.
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D002645:Chickens; D002945:Cisplatin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004247:DNA / Q000378:metabolism; D004273:DNA, Neoplasm / Q000378:metabolism; D004285:Dogs; D004341:Drug Evaluation; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008251:Macaca; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D013329:Structure-Activity Relationship
D000477:Alkylating Agents; D004273:DNA, Neoplasm; D004247:DNA; D002945:Cisplatin